Evidence map›Paper›PMID 34667075›Full record

ArticleCMAJ open

Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.

Nisha Thampi, Braden D Knight, Kednapa Thavorn, Richard J Webster, Krista Lanctot, Steven Hawken, J Dayre McNally

Open access · diamondAbstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nisha ThampiDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont. nthampi@cheo.on.ca.
Braden D KnightDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont.
Kednapa ThavornDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont.
Richard J WebsterDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont.
Krista LanctotDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont.
Steven HawkenDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont.
J Dayre McNallyDepartment of Pediatrics (Thampi, McNally), Faculty of Medicine, University of Ottawa; CHEO Research Institute (Thampi, McNally); ICES uOttawa (Knight); Ottawa Hospital Research Institute (Knight, Thavorn); Clinical Research Unit, CHEO Research Institute (Knight, Webster); Ontario Child Health Support Unit (Knight, Webster); School of Epidemiology and Public Health (Thavorn, Hawken), University of Ottawa, Ottawa, Ont.; ICES Central (Thavorn, Hawken), Toronto, Ont.; Clinical Epidemiology Program (Thavorn), Ottawa, Ont.; Sunnybrook Research Institute (Lanctot), University of Toronto, Toronto, Ont.; Clinical Epidemiology Program (Hawken), Ottawa Hospital Research Institute, Ottawa, Ont.
University of Ottawa · CA

Funding

CIHR
6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) infection poses a substantial clinical burden among infants and young children. We sought to determine the health care costs of hospitalizations attributable to RSV in Ontario, Canada, from the health care payer perspective.

methodsFor this population-based matched cohort study, we identified children younger than 24 months who were or were not hospitalized with RSV infections in 2006-2016. We performed a cost-of-illness analysis using linked administrative health data, with subjects stratified by gestational age and congenital heart disease, and propensity score-matched on established risk factors. The primary outcome was attributable health care costs per patient, reflecting the difference in direct medical costs between the groups, calculated to 12 months postdischarge in 2020 Canadian dollars.

resultsWe identified 14 608 RSV-infected children, matched to 72 040 controls. The adjusted attributable cost of hospitalized RSV was $134 931 900 over 10 years, or $9240 per patient (95% confidence interval [CI] $8790-$9690). Health care costs escalated 3 days before hospitalization, and persisted up to 12 months after discharge. Increased costs were associated with major comorbidities, but not extreme premature birth. The highest mean attributable cost per patient was in the presence of hemodynamically significant heart disease ($60 110, 95% CI $26 700-$93 060). Infants born at 36-43 weeks' gestation constituted the greatest overall cost burden at $117 886 720.

interpretationAlthough the greatest direct medical costs per patient hospitalized with RSV infection are among children with cardiac disease, the greatest overall cost burden is from children born at or near term, who are not targeted by current prophylaxis strategies. The substantial attributable health care costs of RSV can inform cost-effectiveness analyses of novel RSV vaccines and prioritization of health care resources.

Indexed as

Cost of IllnessHospitalizationRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesComorbidityCost-Benefit AnalysisFemaleGestational AgeHealth Care CostsHealth Services Needs and DemandHeart Defects, CongenitalHumansInfantMaleOntarioPremature BirthRespiratory Syncytial Virus Vaccines

Identifiers

PMID34667075
PMCPMC8526091
OpenAlexW3205470627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.